Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Reexamination Certificate
2005-04-21
2008-08-26
Robinson, Hope A (Department: 1652)
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
C435S320100, C435S252000, C435S007100
Reexamination Certificate
active
07416861
ABSTRACT:
The present invention relates to novel human coagulation Factor VIIa variants having coagulant activity as well as polynucleotide constructs encoding such variants, vectors and host cells comprising and expressing the polynucleotide, pharmaceutical compositions, uses and methods of treatment.
REFERENCES:
patent: 5288629 (1994-02-01), Berkner
patent: 5580560 (1996-12-01), Nicolaisen et al.
patent: 5874407 (1999-02-01), Kelley et al.
patent: 5994296 (1999-11-01), Ruf et al.
patent: 2003/0096338 (2003-05-01), Pedersen et al.
patent: 2003/0130191 (2003-07-01), Persson et al.
patent: 2003/0170863 (2003-09-01), Persson et al.
patent: 0 200 421 (1986-12-01), None
patent: 10/59866 (1998-03-01), None
patent: 88/10295 (1987-06-01), None
patent: 94/07515 (1992-10-01), None
patent: 94/27631 (1994-05-01), None
patent: WO 96/12800 (1996-05-01), None
patent: 97/20939 (1996-11-01), None
patent: 98/31394 (1998-01-01), None
patent: 01/58935 (2001-08-01), None
patent: 01/75086 (2001-10-01), None
patent: 01/82943 (2001-11-01), None
patent: 01/83725 (2001-11-01), None
patent: 01/85198 (2001-11-01), None
patent: 02/22776 (2002-03-01), None
patent: 02/38162 (2002-05-01), None
patent: 02/062376 (2002-08-01), None
patent: 02/077218 (2002-10-01), None
patent: 03/027147 (2003-04-01), None
U.S. Appl. No. 60/184,036, filed Feb. 22, 2000.
Neuenschwander et al., Biochemistry, vol. 34, pp. 8701-8707 (1995).
Bernardi et al., Human Mutation, vol. 8, pp. 108-115 (1996).
Chang et al., Biochemistry, vol. 38, pp. 10940-10948 (1999).
Leonard et al., Abstract 1474, Journ of Int Soc Thromb and Haemost., p. 466 (Suppl. Aug. 1999).
Iakhiev et al., Thromb and Haemost, vol. 85 (3), pp. 458-463 (2001) Jin et al., Journ of Mol Bio, vol. 307 (part 5), pp. 1503-1517.
Persson et al., Journ of Biol Chem, vol. 276 (31), pp. 29195-29199 (2001).
International Search Report (Aug. 25, 2003).
International Search Report (Feb. 5, 2004).
Peyvandi et al., Throm Haemost, vol. 84, pp. 250-257 (2000).
Peyvandi et al., Throm Haemost, vol. 88, pp. 750-755 (2002).
Soejima et al., Journ of Bio Chem, vol. 276 (20), pp. 17229-17235 (2001).
U.S. Apppl. No. 10/415,963, filed May 5, 2003, Ruf et al.
Dickinson et al., Proc. Natl Acad Sci USA, vol. 93, pp. 14379-14384 (1996).
Abstract of Mizuguchi et al., Journal of the International Society on Thrombosis and Haemostasis, p. 466 (Supplement 1999).
Jianping Jin, Ph.D., UMI Dissertation Services,pp. ii-114 (1999).
Abstract of Kumar A. Fair, D.S., European Journal of Biochemistry (Germany), vol. 217, No. 2, pp. 509-518 (1993).
Stenesh, J., Dict of Biochem and Molec Bio 2ndED., p. 97 (Oct. 18, 1989).
Olsen Ole Hvilsted
Persson Egon
Green Reza
Novo Nordisk Healthcare A/G
Robinson Hope A
LandOfFree
Human coagulation factor VII polypeptides does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Human coagulation factor VII polypeptides, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Human coagulation factor VII polypeptides will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3996368